iRhythm Technologies Management
Management criteria checks 1/4
iRhythm Technologies' CEO is Quentin Blackford, appointed in Oct 2021, has a tenure of 2.58 years. total yearly compensation is $16.60M, comprised of 4.1% salary and 95.9% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth €5.91M. The average tenure of the management team and the board of directors is 1.9 years and 6.8 years respectively.
Key information
Quentin Blackford
Chief executive officer
US$16.6m
Total compensation
| CEO salary percentage | 4.1% |
| CEO tenure | 2.6yrs |
| CEO ownership | 0.2% |
| Management average tenure | 1.9yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$130m |
| Dec 31 2023 | US$17m | US$677k | -US$123m |
| Sep 30 2023 | n/a | n/a | -US$105m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$105m |
| Dec 31 2022 | US$8m | US$650k | -US$116m |
| Sep 30 2022 | n/a | n/a | -US$128m |
| Jun 30 2022 | n/a | n/a | -US$131m |
| Mar 31 2022 | n/a | n/a | -US$124m |
| Dec 31 2021 | US$10m | US$163k | -US$101m |
Compensation vs Market: Quentin's total compensation ($USD16.60M) is above average for companies of similar size in the German market ($USD1.99M).
Compensation vs Earnings: Quentin's compensation has increased whilst the company is unprofitable.
CEO
Quentin Blackford (44 yo)
2.6yrs
Tenure
US$16,595,149
Compensation
Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.6yrs | US$16.60m | 0.23% $ 5.9m | |
| Chief Financial Officer | 1.8yrs | US$5.28m | 0.0085% $ 216.7k | |
| Chief Medical & Scientific Officer and Executive VP of Product Innovation | 2.1yrs | US$5.32m | 0.011% $ 283.8k | |
| Chief Business & Legal Officer | 2.4yrs | US$5.33m | 0.031% $ 780.9k | |
| Chief Commercial Officer | 1.8yrs | US$5.77m | 0.017% $ 435.9k | |
| Executive Vice President of Business Operations | less than a year | no data | no data | |
| Senior VP of Finance & Chief Accounting Officer | less than a year | no data | no data | |
| Executive VP of Corporate Development & Investor Relations | 4.9yrs | US$3.54m | 0.098% $ 2.5m | |
| Executive Advisor | 1.2yrs | US$2.72m | 0.055% $ 1.4m | |
| Executive VP & Chief Risk Officer | 2yrs | no data | 0.079% $ 2.0m | |
| Director of Investor Relations | no data | no data | no data |
1.9yrs
Average Tenure
44yo
Average Age
Experienced Management: I25's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.3yrs | US$16.60m | 0.23% $ 5.9m | |
| Independent Director | 6.8yrs | US$233.12k | 0.028% $ 710.8k | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.8yrs | US$240.25k | 0.026% $ 657.6k | |
| Independent Chairman | 8yrs | US$286.74k | 0.029% $ 739.0k | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.1yrs | US$230.62k | 0.014% $ 357.8k | |
| Independent Director | 8.2yrs | US$248.12k | 0.030% $ 751.4k | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.5yrs | US$239.97k | 0.011% $ 288.9k | |
| Medical Director & Member of Scientific Advisory Board | no data | no data | no data |
6.8yrs
Average Tenure
66yo
Average Age
Experienced Board: I25's board of directors are considered experienced (6.8 years average tenure).